<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.0 20040830//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09-PONE-RA-11975R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0007512</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Cell Biology/Cellular Death and Stress Responses</subject><subject>Virology/Host Antiviral Responses</subject><subject>Virology/Immune Evasion</subject></subj-group></article-categories><title-group><article-title>Caspase-Dependent Inhibition of Mousepox Replication by gzmB</article-title><alt-title alt-title-type="running-head">Granzyme B and Mousepox</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Pardo</surname><given-names>Juli&#x000e1;n</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib><contrib contrib-type="author"><name><surname>G&#x000e1;lvez</surname><given-names>Eva Ma</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Koskinen</surname><given-names>Aulikki</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Simon</surname><given-names>Markus M.</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lobigs</surname><given-names>Mario</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Regner</surname><given-names>Matthias</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>M&#x000fc;llbacher</surname><given-names>Arno</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Departamento Bioqu&#x000ed;mica y Biolog&#x000ed;a Molecular y Celular, Facultad de Ciencias, Universidad de Zaragoza, Zaragoza, Spain</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Fundaci&#x000f3;n Arag&#x000f3;n I&#x0002b;D (ARAID), Gobierno de Arag&#x000f3;n, Spain</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Instituto de Carboqu&#x000ed;mica, CSIC, Zaragoza, Spain</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Viral Immunology Group, Division of Immunology and Genetics, The John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia</addr-line></aff><aff id="aff5"><label>5</label><addr-line>Molecular Virology Group, Division of Immunology and Genetics, The John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia</addr-line></aff><aff id="aff6"><label>6</label><addr-line>Metschnikoff Laboratory, Max-Planck Institute for Immunobiology, Freiburg, Germany</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>H&#x000e4;cker</surname><given-names>Georg</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Technical University Munich, Germany</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>pardojim@unizar.es</email> (JP); <email>Matthias.Regner@anu.edu.au</email> (MR); <email>arno.mullbacher@anu.edu.au</email> (AM)</corresp><fn fn-type="con"><p>Conceived and designed the experiments: JP EMG MMS ML MR AM. Performed the experiments: JP EMG AK MR. Analyzed the data: JP EMG AK ML MR AM. Contributed reagents/materials/analysis tools: JP MMS ML MR AM. Wrote the paper: JP EMG MMS MR AM.</p></fn></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>19</day><month>10</month><year>2009</year></pub-date><volume>4</volume><issue>10</issue><elocation-id>e7512</elocation-id><history><date date-type="received"><day>30</day><month>7</month><year>2009</year></date><date date-type="accepted"><day>30</day><month>9</month><year>2009</year></date></history><permissions><copyright-statement>Pardo et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract><sec><title>Background</title><p>Ectromelia virus is a natural mouse pathogen, causing mousepox. The cytotoxic T (Tc) cell granule serine-protease, granzyme B, is important for its control, but the underlying mechanism is unknown. Using <italic>ex vivo</italic> virus immune Tc cells, we have previously shown that granzyme B is able to activate several independent pro-apoptotic pathways, including those mediated by Bid/Bak/Bax and caspases-3/-7, in target cells pulsed with Tc cell determinants.</p></sec><sec><title>Methods and Findings</title><p>Here we analysed the physiological relevance of those pro-apoptotic pathways in ectromelia infection, by incubating ectromelia-immune <italic>ex vivo</italic> Tc cells from granzyme A deficient (GzmB<sup>&#x0002b;</sup> Tc cells) or granzyme A and granzyme B deficient (GzmA&#x000d7;B<sup>&#x02212;/&#x02212;</sup> Tc cell) mice with ectromelia-infected target cells. We found that gzmB-induced apoptosis was totally blocked in ectromelia infected or peptide pulsed cells lacking caspases-3/-7. However ectromelia inhibited only partially apoptosis in cells deficient for Bid/Bak/Bax and not at all when both pathways were operative suggesting that the virus is able to interfere with apoptosis induced by gzmB in case not all pathways are activated. Importantly, inhibition of viral replication <italic>in vitro</italic>, as seen with wild type cells, was not affected by the lack of Bid/Bak/Bax but was significantly reduced in caspase-3/-7-deficient cells. Both caspase dependent processes were strictly dependent on gzmB, since Tc cells, lacking both gzms, neither induced apoptosis nor reduced viral titers.</p></sec><sec><title>Significance</title><p>Out findings present the first evidence on the biological importance of the independent gzmB-inducible pro-apoptotic pathways in a physiological relevant virus infection model.</p></sec></abstract><counts><page-count count="11"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Cytotoxic T (Tc) lymphocytes and natural killer (NK) cells are key components of the host immune system protecting against tumor development and intracellular pathogens, in particular viruses. In vitro, they kill virus-infected or transformed cells by a mechanism known as &#x02018;programmed cell death&#x02019;, apoptosis <xref ref-type="bibr" rid="pone.0007512-Wyllie1">&#x0005b;1&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007512-Russell1">&#x0005b;2&#x0005d;</xref>. Tc cells employ two major mechanisms to induce apoptosis of target cells: one is via the engagement of a death receptor on the cell surface of target cells by a specific ligand (death ligand) expressed by Tc cells (i.e. CD95 (Fas)/CD95L (FasL)) <xref ref-type="bibr" rid="pone.0007512-Rouvier1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007512-Kagi1">&#x0005b;4&#x0005d;</xref> and the other is the granule exocytosis pathway <xref ref-type="bibr" rid="pone.0007512-Kagi1">&#x0005b;4&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007512-AshtonRickardt1">&#x0005b;5&#x0005d;</xref>.</p><p>The granule exocytosis pathway consists of the intracellular mobilization and release of the content of specialized organelles (cytotoxic granules) via the immunological synapse <xref ref-type="bibr" rid="pone.0007512-Bossi1">&#x0005b;6&#x0005d;</xref>. The principal granule components with cytotoxic potential are the pore forming protein perforin (perf) <xref ref-type="bibr" rid="pone.0007512-Voskoboinik1">&#x0005b;7&#x0005d;</xref> and a family of serine-proteases named granzymes (gzm), of which gzmA <xref ref-type="bibr" rid="pone.0007512-Simon1">&#x0005b;8&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007512-Lieberman1">&#x0005b;9&#x0005d;</xref> and gzmB <xref ref-type="bibr" rid="pone.0007512-Trapani1">&#x0005b;10&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007512-Tschopp1">&#x0005b;11&#x0005d;</xref> are the most abundant and best characterized. The availability of mice deficient in one or more of these cytolytic effector molecules has provided evidence of their role in controlling virus infections <xref ref-type="bibr" rid="pone.0007512-Kagi2">&#x0005b;12&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007512-Wang1">&#x0005b;17&#x0005d;</xref> and protection from tumours <xref ref-type="bibr" rid="pone.0007512-Pardo1">&#x0005b;18&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007512-vandenBroek2">&#x0005b;22&#x0005d;</xref>. This control is facilitated by the induction of apoptosis via one of two major pathways, either the extrinsic (activated by death receptor engagement) or the intrinsic or mitochondrial-mediated (activated by cellular stress) apoptotic pathway. At least three main interconnected cellular components have been shown to be responsible for activation and/or regulation of those pathways: the caspases <xref ref-type="bibr" rid="pone.0007512-Turk1">&#x0005b;23&#x0005d;</xref>, the transcription factor p53 <xref ref-type="bibr" rid="pone.0007512-Chipuk1">&#x0005b;24&#x0005d;</xref> and the Bcl-2 family, consisting of pro-apoptotic (Bid, Bak, Bax, Bim, etc.) and anti-apoptotic (Bcl-2, Bcl-X<sub>L</sub>, Mcl-1, etc.) proteins <xref ref-type="bibr" rid="pone.0007512-Adams1">&#x0005b;25&#x0005d;</xref>.</p><p>Viruses have been shown to interfere with the above-mentioned apoptotic mechanisms in order to optimize their replication in the host cell <xref ref-type="bibr" rid="pone.0007512-Benedict1">&#x0005b;26&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007512-Callus1">&#x0005b;28&#x0005d;</xref>. Ortho-poxviruses encode a number of apoptosis inhibitors. Members of this family, vaccinia virus (VACV), cowpox (CPXV) and rabbit pox (RPXV) are able to block the extrinsic, death receptor-mediated, as well as the intrinsic pathways. Extrinsic and mitochondrial apoptotic processes are inhibited through either the viral CrmA-like caspase-8/-10 inhibitor SPI-2 <xref ref-type="bibr" rid="pone.0007512-Dobbelstein1">&#x0005b;29&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007512-Pickup1">&#x0005b;31&#x0005d;</xref>, and/or the Bak and BH3-only inhibitor F1L <xref ref-type="bibr" rid="pone.0007512-Fischer1">&#x0005b;32&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007512-Postigo1">&#x0005b;34&#x0005d;</xref> or the Bcl-2 homologue N1L <xref ref-type="bibr" rid="pone.0007512-Aoyagi1">&#x0005b;35&#x0005d;</xref>, respectively. Ectromelia virus (ECTV) is the causative agent of mousepox and also an orthopoxvirus <xref ref-type="bibr" rid="pone.0007512-Fenner1">&#x0005b;36&#x0005d;</xref>. Unlike VACV, CPXV and RPXV, ECTV is a natural pathogen of mice. ECTV infection of mice is therefore uniquely able to provide physiologically relevant insights into co-evolved host-pathogen relationships. Like other orthopoxviruses, ECTV is able to inhibit death receptor-induced apoptosis by SPI-2 expression <xref ref-type="bibr" rid="pone.0007512-Mullbacher2">&#x0005b;37&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007512-Turner1">&#x0005b;39&#x0005d;</xref> and UV-induced apoptosis by the ring finger protein p28 in vitro <xref ref-type="bibr" rid="pone.0007512-Brick1">&#x0005b;40&#x0005d;</xref>. In addition, N1L and F1L orthologues are found in the ECTV genome <xref ref-type="bibr" rid="pone.0007512-Chen1">&#x0005b;41&#x0005d;</xref>.</p><p>Perf, gzmA and gzmB are all important for <italic>in vivo</italic> ECTV control, <xref ref-type="bibr" rid="pone.0007512-Mullbacher1">&#x0005b;13&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007512-Mllbacher1">&#x0005b;14&#x0005d;</xref>. GzmA and/or gzmB are crucial for perf-mediated induction of apoptosis by <italic>ex-vivo</italic> virus-immune Tc cells <xref ref-type="bibr" rid="pone.0007512-Pardo2">&#x0005b;42&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007512-Simon2">&#x0005b;45&#x0005d;</xref>, albeit not for cellular lysis, as observed by <sup>51</sup>Cr release <xref ref-type="bibr" rid="pone.0007512-Pardo2">&#x0005b;42&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007512-Simon2">&#x0005b;45&#x0005d;</xref>. These results, together with the inability of ECTV to inhibit cellular lysis induced by perf/gzms <xref ref-type="bibr" rid="pone.0007512-Mullbacher2">&#x0005b;37&#x0005d;</xref>, suggest that apoptotic cell death induction by gzmA and/or gzmB may be crucial for the recovery of mice from ECTV infection.</p><p>GzmB of virus-immune <italic>ex vivo</italic> Tc cells activates several distinct pro-apoptotic pathways including those mediated by caspases and the Bcl-2 family <xref ref-type="bibr" rid="pone.0007512-Pardo3">&#x0005b;43&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007512-Pardo4">&#x0005b;44&#x0005d;</xref>. Since gzmB is important in the control of ECTV infection and ECTV is able to inhibit a number of apoptotic pathways, we speculated that the pleiotropic effect of mouse gzmB has evolved to counteract virus evasion strategies of apoptosis. We tested this hypothesis, by using <italic>ex vivo</italic> ECTV-immune Tc cells to analyse the effect of ECTV infection during apoptosis induced by perf/gzmB. Our results indicate that ECTV is not able to inhibit apoptosis induced by <italic>ex vivo</italic> Tc cells, which is critically dependent on gzmB expression. In addition, this process correlates with reduced ECTV replication in infected target cells. Further analysis of those processes in target cells deficient in the mitochondrial or caspase apoptotic pathways reveal the relative importance of these pathways to induce apoptosis in ECTV infected cells and to inhibit ECTV replication.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Infection of MEF cells by ECTV</title><p>To analyze the putative inhibitory effect of ECTV on apoptosis induced by gzmB we used ECTV-immune <italic>ex vivo</italic>-derived Tc cells from gzmA<sup>&#x02212;/&#x02212;</sup> mice (gzmB<sup>&#x0002b;</sup> Tc cells) as effector cells, and three mouse embryonic fibroblast (MEF) lines, wild type (wt), and two lines derived from mutant mice deficient in either the proapototic molecules Bak and Bax (MEF.BakxBax<sup>&#x02212;/&#x02212;</sup>) or the caspases 3 and 7 (MEF.Casp3x7<sup>&#x02212;/&#x02212;</sup>) as target cells. All cell lines have previously been shown to be susceptible to gzmB<sup>&#x0002b;</sup> Tc-induced cell death <xref ref-type="bibr" rid="pone.0007512-Pardo4">&#x0005b;44&#x0005d;</xref>.</p><p>We initially characterized permissibility of MEFs to infection with virulent ECTV Moscow (Mo) strain and attenuated ECTV Hampstead Egg (HE) strain. Both virus strains replicated with similar efficiency in all cell lines, as evidenced by viral plaque assays (data not shown). In addition, intracellular FACS staining of virus with anti-ECTV rabbit serum indicated that at 4 or 24 h after virus infection, similar percentages of cells became antibody positive with either Mo- or HE-ECTV strains (<xref ref-type="supplementary-material" rid="pone.0007512.s001">Fig. S1A</xref>). Furthermore, we found that mRNA of the EVM025 protein (the ECTV orthologue of the VACV F1L protein, a specific inhibitor of Bak, a proapoptotic member of the Bcl-2 family <xref ref-type="bibr" rid="pone.0007512-Fischer1">&#x0005b;32&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007512-Postigo1">&#x0005b;34&#x0005d;</xref>) was already expressed after 4 h in Mo- or HE-ECTV infected (MOI 3&#x02236;1 (3 pfu/cell)) but not mock treated cells and also contained the BH3-like domain responsible for Bak inhibition (<xref ref-type="supplementary-material" rid="pone.0007512.s001">Fig. S1B</xref>). In addition, as reported for VV <xref ref-type="bibr" rid="pone.0007512-Fischer1">&#x0005b;32&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007512-Postigo1">&#x0005b;34&#x0005d;</xref>, Mo- and HE-ECTV inhibited apoptosis induced by the bacterial metabolite staurosporin, most probably via VACV F1L (STP. <xref ref-type="supplementary-material" rid="pone.0007512.s001">Fig. S1C</xref>). At 4&#x02013;8 h after infection, cells are still viable and cell death markers are not yet detectable (<xref ref-type="supplementary-material" rid="pone.0007512.s001">Fig S1D</xref>). These data indicate that MEFs are efficiently infected by Mo- and HE-ECTV. In addition, they show that Mo/HE-ECTV express putative apoptosis inhibitors in infected targets early in the virus replication phase, before the infected cells die as a consequence of viral cytopathic effects (&#x0003e;24 h post infection).</p></sec><sec id="s2b"><title><italic>In vivo</italic> generation of ECTV-immune Tc cells</title><p>To generate Tc cells immune to ECTV, we infected wt or gzmA&#x000d7;B cluster<sup>&#x02212;/&#x02212;</sup> mice (which are deficient in gzmA and gzmB, but also display a reduced expression of several gzmB-downstream gzm <xref ref-type="bibr" rid="pone.0007512-Pham1">&#x0005b;46&#x0005d;</xref>) with 10<sup>5</sup> PFU HE-ECTV intravenously (iv). We used the attenuated HE-ECTV, because Mo-ECTV causes severe liver and spleen destruction in gzmA&#x000d7;B<sup>&#x02212;/&#x02212;</sup> mice, rendering an analysis of splenocytes not feasible <xref ref-type="bibr" rid="pone.0007512-Mllbacher1">&#x0005b;14&#x0005d;</xref>. At 6 d post-infection splenic CD8&#x0002b; cells were enriched and found to express gzmA, gzmB and gzmK mRNA but not gzmC in wt animals (<xref ref-type="supplementary-material" rid="pone.0007512.s002">Fig. S2A</xref>). As expected <xref ref-type="bibr" rid="pone.0007512-Pardo4">&#x0005b;44&#x0005d;</xref>, gzmB<sup>&#x0002b;</sup> Tc cells expressed only gzmB and gzmK, and gzmA&#x000d7;B<sup>&#x02212;/&#x02212;</sup> Tc cells only gzmK. Primary <italic>in vitro</italic> alloreactive B6 wt Tc cells expressed also gzmC. Proteins for gzmA and gzmB were similarly expressed in wt Tc cells, whereas, as expected, only gzmB was produced in gzmB<sup>&#x0002b;</sup> Tc cells and neither of them in gzmA&#x000d7;B<sup>&#x02212;/&#x02212;</sup> Tc cells (<xref ref-type="supplementary-material" rid="pone.0007512.s002">Fig. S2B</xref>). CFSE labelled, <italic>ex vivo</italic> Tc cells were tested for their cytolytic potential against mock-treated, ECTV-infected or peptide-pulsed MEFs and CFSE negative cells (target cells) were analysed for induction of the following proapoptotic features: PS translocation using Annexin V staining and membrane integrity by 7-amino actinomycin D staining (i.e. annexinV<sup>&#x0002b;</sup>/AAD<sup>&#x02212;</sup> equates with early apoptosis, AnnexinV<sup>&#x0002b;</sup>/AAD<sup>&#x0002b;</sup> is indicative of secondary necrosis). We found that B6 and gzmA<sup>&#x02212;/&#x02212;</sup><italic>ex vivo</italic> Tc cells specifically induced apoptosis in ECTV-infected and peptide-pulsed MEFs (<xref ref-type="supplementary-material" rid="pone.0007512.s002">Fig. S2C</xref>). In contrast, gzmA&#x000d7;B<sup>&#x02212;/&#x02212;</sup> derived Tc cells did not induce specific apoptosis (<xref ref-type="supplementary-material" rid="pone.0007512.s002">Fig. S2C</xref>). This indicates that ECTV-immune <italic>ex vivo</italic> Tc cells require gzmB to efficiently induce cell death markers (apoptosis: annexin V or necrosis: AAD)) in MEFs. Similar conclusions have been reached previously using peptide-pulsed targets in the LCMV mouse model <xref ref-type="bibr" rid="pone.0007512-Pardo3">&#x0005b;43&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007512-Pardo4">&#x0005b;44&#x0005d;</xref>.</p><p><xref ref-type="sec" rid="s2">Results</xref> obtained with different target cells, MC57G or EL4.F15 cells, confirmed the results obtained with MEFs (<xref ref-type="fig" rid="pone-0007512-g001">Fig. 1</xref> vs <xref ref-type="supplementary-material" rid="pone.0007512.s002">Fig. S2C</xref>): Only gzmB<sup>&#x0002b;</sup> Tc cells, but not gzmA&#x000d7;B<sup>&#x02212;/&#x02212;</sup> derived ECTV-immune <italic>ex vivo</italic> Tc cells could induce significant apoptosis on peptide-pulsed or ECTV-infected target cells. These results are consistent with the high susceptibility of gzmA&#x000d7;B<sup>&#x02212;/&#x02212;</sup> mice to ECTV infection and suggest that pro-apoptotic processes induced by perf and gzms may be responsible for the gzm-dependent recovery from ECTV infection. In addition, they show that lack of gzmA does not affect the pro-apoptotic potential of ECTV-immune <italic>ex vivo</italic> Tc cells in vitro. For these reasons, we used ECTV-immune <italic>ex vivo</italic> Tc cells from gzmA<sup>&#x02212;/&#x02212;</sup> mice (gzmB<sup>&#x0002b;</sup> Tc cells) as effector cells in all further experiments.</p><fig id="pone-0007512-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007512.g001</object-id><label>Figure 1</label><caption><title>Apoptosis induced by <italic>ex vivo</italic> ECTV-immune Tc cells on target cells.</title><p>CFSE labelled ect <italic>ex vivo</italic> Tc cells (C, B6, gzmA<sup>&#x02212;/&#x02212;</sup> or gzmA&#x000d7;B<sup>&#x02212;/&#x02212;</sup>; D, gzmA<sup>&#x02212;/&#x02212;</sup> or gzmA&#x000d7;B<sup>&#x02212;/&#x02212;</sup>) were incubated with mock-treated, peptide-pulsed or Mo-ECTV-infected (5 h, MOI&#x0200a;&#x0003d;&#x0200a;3) MEF.wt, EL4 and MC57G cells for 3 h. Early (AV<sup>&#x0002b;</sup>/AAD<sup>&#x02212;</sup>, filled bars) and late apoptotic/necrotic (AV<sup>&#x0002b;</sup>/AAD<sup>&#x0002b;</sup>, empty bars) cells in the CFSE<sup>&#x02212;</sup> negative cell population (target cells) were analysed by FACS. Data are given as mean&#x0002b;/&#x02212;SEM of 2 independent experiments.</p></caption><graphic xlink:href="pone.0007512.g001"/></fig></sec><sec id="s2c"><title>ECTV does not inhibit PS translocation induced by <italic>ex vivo</italic> immune gzmB<sup>&#x0002b;</sup>Tc cells</title><p>As we wanted to see whether ECTV virulence correlated with inhibition of gzmB-induced apoptosis, we compared apoptosis induction by ex vivo gzmB<sup>&#x0002b;</sup> Tc cells on MEFs infected with either the virulent Mo-ECTV or the attenuated HE- strain. As controls we used peptide-pulsed or mock-treated MEFs. We first determined whether Mo- and HE-ECTV, render target cells similar recognizable to ECTV-immune <italic>ex vivo</italic> Tc cells. We analysed Tc cell degranulation (by measuring the number of Tc cells expressing the lysosomal marker, CD107a (Lamp1), on their cell membrane, <xref ref-type="bibr" rid="pone.0007512-Pardo4">&#x0005b;44&#x0005d;</xref>) after incubation with ECTV-infected, peptide-pulsed or mock treated MEFs (<xref ref-type="fig" rid="pone-0007512-g002">Fig 2A</xref>). No significant differences in the proportion of CD107a<sup>&#x0002b;</sup> Tc cells after incubation with MEF infected with either strain of ECTV was found. Thus, <italic>ex vivo</italic> ECTV-immune Tc cells recognise MEF with similar efficiency after infection with either virulent or attenuated ECTV, and degranulation correlated with apoptosis induced by gzmB<sup>&#x0002b;</sup> Tc cells on MEFs (<xref ref-type="fig" rid="pone-0007512-g002">Fig 2B</xref>). GzmB<sup>&#x0002b;</sup> Tc cells induced apoptosis to the same extend on peptide-pulsed and Mo- or HE-ECTV infected MEFs (4&#x02013;5 h post-infection) compared to mock-treated targets (<xref ref-type="fig" rid="pone-0007512-g002">Fig. 2B</xref>). Together with the previous findings that apoptosis (measured by PS translocation) was neither affected by virulent Mo-ECTV in two other cell lines tested, EL4 and MC57G (<xref ref-type="fig" rid="pone-0007512-g001">Fig. 1</xref>), the data suggest that cell death in these target cells is not altered by the virus.</p><fig id="pone-0007512-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007512.g002</object-id><label>Figure 2</label><caption><title>Degranulation of <italic>ex vivo</italic> gzmB<sup>&#x0002b;</sup> Tc cell and PS translocation on target cells.</title><p>MEF.wt cells were mocked-treated, peptide-pulsed or infected (5 h) with Mo- or HE-ECTV. A, MEF-wt target cells were incubated for 5 h with <italic>ex vivo</italic> Tc cells in the presence of monensin and anti-CD107a (FITC), followed by FACS staining with anti-CD8 (APC) and anti-CD107a (FITC). Representative dot plots (with &#x00025; of cells in top right and bottom right quadrants) and means&#x0002b;/&#x02212;SEM of percent CD107a<sup>&#x0002b;</sup> CD8<sup>&#x0002b;</sup> cells are shown from 5 independent experiments performed by duplicate. B, MEF-wt target cells were incubated with CFSE labelled <italic>ex vivo</italic> Tc cells for 3 h and PS translocation (annexin V-PE staining) and membrane integrity (AAD staining) were analysed by FACS in the CFSE<sup>&#x02212;</sup> negative cell population (target cells). Data are given as mean&#x0002b;/&#x02212;SEM of 10 independent experiments.</p></caption><graphic xlink:href="pone.0007512.g002"/></fig><p>Together, these findings indicate that gzmB of <italic>ex vivo</italic> ECTV-immune Tc cells is able to overcome the anti-apoptotic potential of ECTV that is evident against staurosporine.</p></sec><sec id="s2d"><title>ECTV does not inhibit other apoptotic markers induced by <italic>ex vivo</italic> gzmB<sup>&#x0002b;</sup> Tc cells</title><p>Although gzmB<sup>&#x0002b;</sup> Tc cell-mediated PS translocation was not inhibited in MEFs infected with ECTV viruses, we investigated whether other pro-apoptotic features, elicited by gzmB, may be affected. ECTV-immune <italic>ex vivo</italic> gzmB<sup>&#x0002b;</sup> Tc cells were incubated with MEFs either mock, peptide-pulsed or Mo- or HE-ECTV-infected and monitored for a) loss of mitochondrial membrane potential by staining with DiOC<sub>6</sub>(3), (<xref ref-type="fig" rid="pone-0007512-g003">Fig. 3A</xref>), b) caspase 3 activation by staining with anti-active caspase-3 antibody, (<xref ref-type="fig" rid="pone-0007512-g003">Fig. 3B</xref>) and c) conformational changes of Bak and Bax by staining with mAbs that recognise N-terminal epitopes of Bak and Bax, respectively, which are exposed only upon their functional activation (<xref ref-type="fig" rid="pone-0007512-g003">Fig. 3C</xref>). None of the parameters tested were significantly affected as a result of ECTV infection (<xref ref-type="supplementary-material" rid="pone.0007512.s001">Fig. S1D</xref>), although an increased caspase 3 activation in ECTV infected target cells was observed (<xref ref-type="fig" rid="pone-0007512-g003">Fig. 3B</xref>), which possibly reflected early caspase 3 induction by ECTV itself <xref ref-type="bibr" rid="pone.0007512-Krzyzowska1">&#x0005b;47&#x0005d;</xref>.</p><fig id="pone-0007512-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007512.g003</object-id><label>Figure 3</label><caption><title><italic>Ex vivo</italic> gzmB<sup>&#x0002b;</sup> Tc cell-induced mitochondrial damage, caspase 3 activation, Bak/Bax conformational change and calreticulin translocation in ECTV-infected targets.</title><p>Mock-treated, peptide-pulsed or Mo-ECTV-infected MEF.wt cells were incubated with CFSE labelled (C) or unlabelled (A, B) <italic>ex vivo</italic> Tc cells for 3 h and mitochondrial membrane potential (DiOC<sub>6</sub>(3), A) caspase 3 activation (anti-active caspase 3-FITC antibody, B) were analysed in the CD8<sup>&#x02212;</sup> population by FACS or Bak and Bax conformational change (anti-N-terminal Bak/Bax antibodies, C) and calreticulin translocation (D) in the CFSE<sup>&#x02212;</sup> cell population. Data are given as mean&#x0002b;/&#x02212;SEM of percent positive cells from 4 (A), 3 (B), 2 (C) or 4 (D) independent experiments.</p></caption><graphic xlink:href="pone.0007512.g003"/></fig></sec><sec id="s2e"><title><italic>Ex vivo</italic> ECTV-immune gzmB<sup>&#x0002b;</sup> Tc cells induce calreticulin translocation, independently of ECTV infection</title><p>It was possible that ECTV affects the quality of cell death thereby evading specific immunity in order to hide of the immune system. It is well established that, under certain conditions, dying cells express particular signals relevant for the induction of immune responses, including immunological memory formation. One of these signals is calreticulin, which may be exposed on membranes of dying cells <xref ref-type="bibr" rid="pone.0007512-Gardai1">&#x0005b;48&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007512-Obeid1">&#x0005b;49&#x0005d;</xref>. We tested calreticulin exposure on the outer cell membrane of Tc cell-treated, ECTV-infected target cells. <italic>Ex vivo</italic> gzmB<sup>&#x0002b;</sup> Tc cells were incubated with MEFs (mock, peptide-pulsed or Mo- or HE-ECTV-infected) and calreticulin exposure was analysed by FACS (<xref ref-type="fig" rid="pone-0007512-g003">Fig. 3D</xref>). There was no difference in calreticulin membrane expression induced irrespective whether MEFs were peptide-pulsed or infected with ECTV.</p></sec><sec id="s2f"><title>ECTV inhibits apoptosis induced by ex vivo ECTV- immune gzmB<sup>&#x0002b;</sup> Tc cells in target cells lacking Bak and Bax</title><p>CPXV SPI-2 (CrmA) <xref ref-type="bibr" rid="pone.0007512-Tewari1">&#x0005b;50&#x0005d;</xref>, but not ECTV SPI-2 <xref ref-type="bibr" rid="pone.0007512-Turner1">&#x0005b;39&#x0005d;</xref> was shown to inhibit gzmB in a cell free system or after transient induced expression in a cell line, respectively. Our data indicate that ECTV encoded inhibitors are not able to generally block gzmB<sup>&#x0002b;</sup>Tc cell-mediated apoptosis in wt-MEFs. Thus the question arises; if gzmB's broadly induced apoptosis can only be mediated by one of the two major pathways in virus infected target cells. We therefore used MEF.BakxBax<sup>&#x02212;/&#x02212;</sup> and MEF.Casp3x7<sup>&#x02212;/&#x02212;</sup> (mock-treated, peptide-pulsed or Mo-ECTV-infected) target cells with <italic>ex vivo</italic> ECTV-immune gzmB<sup>&#x0002b;</sup> Tc cells and analysed the induction of pro-apoptotic features (<xref ref-type="fig" rid="pone-0007512-g004">Fig. 4</xref>). In agreement with the LCMV model <xref ref-type="bibr" rid="pone.0007512-Pardo4">&#x0005b;44&#x0005d;</xref>, we found that PS translocation induced by ECTV-immune <italic>ex vivo</italic> gzmB<sup>&#x0002b;</sup>CTLs on both MEF.wt targets, peptide-pulsed and Mo-ECTV-infected, was completely dependent on caspases-3 and/or -7.</p><fig id="pone-0007512-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007512.g004</object-id><label>Figure 4</label><caption><title><italic>Ex vivo</italic> gzmB<sup>&#x0002b;</sup> Tc cell-induced PS translocation in target cells lacking casp 3 and casp 7 or Bak and Bax.</title><p>Mock-treated, peptide-pulsed, or Mo- or HE-ECTV-infected MEF.wt, Casp3x7<sup>&#x02212;/&#x02212;</sup> or BakxBax<sup>&#x02212;/&#x02212;</sup> cells were incubated with CFSE labelled <italic>ex vivo</italic> Tc cells for 3 h. Percent early (AV<sup>&#x0002b;</sup>/AAD<sup>&#x02212;</sup>, filled bars) and late apoptotic/necrotic (AV<sup>&#x0002b;</sup>/AAD<sup>&#x0002b;</sup>, empty bars) cells in the CFSE<sup>&#x02212;</sup> negative cell population (target cells) are given as mean&#x0002b;/&#x02212;SEM of 4 independent experiments.</p></caption><graphic xlink:href="pone.0007512.g004"/></fig><p>This was paralleled in the ECTV system for peptide-pulsed MEF.BakxBax<sup>&#x02212;/&#x02212;</sup>, which were as susceptible to gzmB<sup>&#x0002b;</sup> Tc cell-induced PS exposure as peptide-pulsed MEF.wt. In contrast Mo-ECTV-infected MEF.BakxBax<sup>&#x02212;/&#x02212;</sup> were around 50&#x00025; less susceptible than Mo-ECTV-infected MEF.wt. This suggests that, in the absence of Bak and/or Bax, ECTV interferes with gzmB<italic><sup>&#x0002b;</sup></italic> Tc cell-disrupted plasma membrane asymmetry.</p><p>Since gzmB-facilitated PS translocation is critically dependent on casp3x7 <xref ref-type="bibr" rid="pone.0007512-Pardo4">&#x0005b;44&#x0005d;</xref>, but amplified via mitochondrial processes, including apoptosome/caspase-9 complex formation, this finding provides evidence that the mitochondrial pathway is critical for efficient gzmB-induced apoptosis of ECTV-infected cells.</p></sec><sec id="s2g"><title>GzmB<sup>&#x0002b;</sup> but not gzmA&#x000d7;B<sup>&#x02212;/&#x02212;</sup> Tc cells inhibit ECTV replication <italic>in vitro</italic> by a caspase dependent mechanism</title><p>To address the question, whether differential inhibition of gzmB-induced apoptosis by ECTV affects virus replication, we infected MEF target cells with Mo-ECTV for 3 or 18 h before subjecting them to attack by <italic>ex vivo</italic> wt B6, gzmB<sup>&#x0002b;</sup> or gzmA<sup>&#x0002b;</sup> (gzmB<sup>&#x02212;/&#x02212;</sup>) Tc cells. Viral titers in cultures were analysed after 4 or 44 h of co-incubation. In those targets that had been infected for 18 h before exposure to virus-immune Tc cells, high titers were observed already at the beginning of the co-cultures (<xref ref-type="fig" rid="pone-0007512-g005">Fig. 5A</xref>). These titers did not change over the subsequent 44 h, independent on the presence or absence of virus-immune Tc cells. This suggests that virus had completed a replication cycle before exposure to virus-immune Tc cells, and that virtually all susceptible target cells had been infected and maximally replicated virus. However, early (3 h) after target infection, low titers were observed, consistent with the eclipse phase of virus infection (<xref ref-type="fig" rid="pone-0007512-g005">Fig 5A</xref>). Spleens of the HE-ECTV infected mice that provided the virus-immune Tc cells had no detectable virus at the time of sacrifice (not shown), ruling out a contamination from this source. WT Tc cells were then able to completely suppress any viral replication in these targets, since viral titers in their cultures did not increase over the next 44 h, whereas in the absence of Tc cells, detectable virus increased 100-fold during this time (<xref ref-type="fig" rid="pone-0007512-g005">Fig 5A</xref>). In contrast, exposure to gzmA<sup>&#x0002b;</sup> (gzmB<sup>&#x02212;/&#x02212;</sup>) and gzmB<sup>&#x0002b;</sup> (gzmA<sup>&#x02212;/&#x02212;</sup>) virus-immune Tc cells resulted in a graded suppression of viral replication.</p><fig id="pone-0007512-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007512.g005</object-id><label>Figure 5</label><caption><title><italic>Ex vivo</italic> Tc cells need gzmB to inhibit ECTV replication in vitro by a casp3x7 dependent process.</title><p>A, B, MEF.wt cells were infected for 3 or 18 h before being subjected to attack by <italic>ex vivo</italic> Tc cells from ECTV-immune WT (empty bars), gzmA&#x02212;/&#x02212; (light bars), gzmB&#x02212;/&#x02212; (dark bars) or gzmA&#x000d7;B&#x02212;/&#x02212; (filled bars) mice for 4 (A, left panel) or 44 h (A, right panel, B). Cell suspensions were removed and analysed for viral titers by plaque assay. C, MEF.wt, Casp3x7<sup>&#x02212;/&#x02212;</sup> or BakxBax<sup>&#x02212;/&#x02212;</sup> cells were infected for 3 h before being subjected to attack by <italic>ex vivo</italic> Tc cells from ECTV-immune gzmA<sup>&#x02212;/&#x02212;</sup> mice for 44 h. Cell suspensions were removed and analysed for viral titers by plaque assay. Data in A and B are from separate experiments. Data are given as mean&#x0002b;/&#x02212;SD from two to four replicate cultures. Similar results were obtained in a separate experiment. &#x0002a;&#x0002a; statistically significant (n&#x0200a;&#x0003d;&#x0200a;3&#x02013;4, P&#x0200a;&#x0003d;&#x0200a;0,007); ns, no statistically significant (n&#x0200a;&#x0003d;&#x0200a;3&#x02013;4, P&#x0003e;0,05). Analysed by a two-tailed unrestricted t-student test comparing casp3x7 or BakxBax with wt.</p></caption><graphic xlink:href="pone.0007512.g005"/></fig><p>Next, we tested the ability of gzmA<sup>&#x0002b;</sup>, gzmB<sup>&#x0002b;</sup> or gzmA&#x000d7;B<sup>&#x02212;/&#x02212;</sup> Tc cells to suppress viral titers in targets infected shortly before Tc cell attack (<xref ref-type="fig" rid="pone-0007512-g005">Fig 5B</xref>). We found an increasing ability of Tc cells to suppress ECTV replication, depending on whether they expressed gzmA, gzmB or both. This viral suppression activity <italic>in vitro</italic> correlated with apoptosis induced by those Tc cells (<xref ref-type="fig" rid="pone-0007512-g001">Fig. 1</xref> and <xref ref-type="supplementary-material" rid="pone.0007512.s002">Fig. S2C</xref>) and indicated that gzmB's ability to overcome ECTV inhibition of apoptosis likely has direct effects on virus replication and/or clearance. Furthermore, gzmA also clearly showed an antiviral effect in these assays, despite not contributing to any of the analyzed apoptosis parameters (<xref ref-type="supplementary-material" rid="pone.0007512.s002">Fig. S2C</xref>). Finally, we tested whether the increased resistance of ECTV-infected MEF.BakxBax<sup>&#x02212;/&#x02212;</sup> and MEF.Casp3x7<sup>&#x02212;/&#x02212;</sup> cells to apoptosis induced by gzmB<sup>&#x0002b;</sup> Tc cells yielded a higher ECTV replication rate in those cells. As shown in the experiment in <xref ref-type="fig" rid="pone-0007512-g005">Fig 5C</xref> we found that upon incubation with gzmB<sup>&#x0002b;</sup> Tc cells, ECTV replication was around 10&#x000d7; higher in MEF.Casp3x7<sup>&#x02212;/&#x02212;</sup> compared to both, MEF.wt or BakxBax<sup>&#x02212;/&#x02212;</sup> cells. An independent experiment yielded similar results with a 100-fold difference between wt and casp3x7<sup>&#x02212;/&#x02212;</sup> cells (not shown). This indicated that partial inhibition of gzmB<sup>&#x0002b;</sup>Tc cell mediated apoptosis by ECTV in Bak and Bax-deficient target cells does not interfere with suppression of virus replication in host cells. In addition, the data show for the first time that casp3x7 are not only important during Tc-mediated and gzmB-facilitated apoptosis, but critically involved in the control of ECTV replication <italic>in vitro</italic> and indicate the biological relevance for the caspase dependent apoptotic pathway in gzmB-mediated control of ECTV.</p></sec></sec><sec id="s3"><title>Discussion</title><p>Tc cells <xref ref-type="bibr" rid="pone.0007512-Blanden1">&#x0005b;51&#x0005d;</xref>, and gzmA/B <xref ref-type="bibr" rid="pone.0007512-Mullbacher3">&#x0005b;52&#x0005d;</xref> are essential for the recovery of mice from primary infection by ECTV, mousepox, and it has been assumed that the two gzms mediate their protective effect via apoptosis induction of infected cells through the granule exocytosis pathway. It has previously been shown that ECTV resistant B6 mice become 10 times more susceptible when gzmA is absent and 10<sup>7</sup> times more susceptible when both gzmA and B are lacking, as demonstrated in the gzmA&#x000d7;B<sup>&#x02212;/&#x02212;</sup> cluster knock-out mice <xref ref-type="bibr" rid="pone.0007512-Mllbacher1">&#x0005b;14&#x0005d;</xref>. Most probable, the latter finding is due to the inability of gzmA&#x000d7;B<sup>&#x02212;/&#x02212;</sup> Tc cells to induce pro-apoptotic processes, such as PS translocation or membrane permeabilization in target cells, as demonstrated here with three different types of target cells (EL4 lymphoma, embryonic fibroblasts and MC57G fibrosarcoma). This contrasts with Tc cells from gzmA<sup>&#x02212;/&#x02212;</sup> mice (gzmB<sup>&#x0002b;</sup> Tc cells), which exhibit no defect in their ability to induce apoptosis in ECTV-infected targets. These results are in agreement with previous findings in the LCMV-system <xref ref-type="bibr" rid="pone.0007512-Pardo2">&#x0005b;42&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007512-Simon2">&#x0005b;45&#x0005d;</xref>. Moreover, it would be expected that if ECTV was able to efficiently block gzmB-dependent <italic>in vivo</italic> processes, including apoptosis, gzmA<sup>&#x02212;/&#x02212;</sup> mice should be as susceptible to ECTV infection as gzmA&#x000d7;B<sup>&#x02212;/&#x02212;</sup>, which is not the case <xref ref-type="bibr" rid="pone.0007512-Mllbacher1">&#x0005b;14&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007512-Mullbacher4">&#x0005b;53&#x0005d;</xref>. This is also in agreement with reports showing that gzmB is not inhibited by ECTV encoded serpins (including SPI-2/CrmA) <xref ref-type="bibr" rid="pone.0007512-Wallich1">&#x0005b;38&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007512-Turner1">&#x0005b;39&#x0005d;</xref>. Supporting these arguments are the data presented here that apoptosis induced by gzmB<sup>&#x0002b;</sup> Tc cells is not abolished by ECTV infection. Although, gzmC and gzmF are down regulated in the gzmA&#x000d7;B&#x02212;/&#x02212; cluster KO mouse, the participation of those gzms in ECTV resistance is unlikely because they are not expressed at detectable levels in ECTV-immune Tc cells from B6wt and gzmA&#x02212;/&#x02212; mice.</p><p>The importance of gzmA and gzmB for ECTV control is further supported by our present finding that <italic>ex vivo</italic> ECTV-immune Tc cells from gzmA&#x000d7;B<sup>&#x02212;/&#x02212;</sup> mice are unable to inhibit ECTV replication <italic>in vitro</italic> in infected target cells in spite of the presence of functional perforin present in those effectors. In contrast Tc cells from wt or gzmA&#x02212;/&#x02212; (expressing gzmB) mice reduced ECTV titres more than 100-fold, which correlated with their ability to induce apoptosis in those infected target cells. This was expected since the virus needs a host cell to replicate and ensure that viral progeny is disseminated to infect other cells. However, the timing of the Tc cell encounter with the infected cell appears to be critical. At late stages of infection, apoptosis induction of infected cells appears to have no beneficial effect because viral progeny formation is already complete, and lysis may in fact facilitate the liberation of viral particles. Consistent with this idea, we found that wt or gzmB<italic><sup>&#x0002b;</sup></italic>Tc cells are not able to reduce viral titers if virus infection had progressed for 18 h (in contrast to infection for 3 h) prior to Tc cell addition. Interestingly, gzmA also showed an inhibitory effect on viral replication <italic>in vitro</italic>, consistent with its demonstrable role in resistance of mice from mousepox. The fact that we did not detect any contribution of gzmA to target cell apoptosis means that either it mediates apoptosis by pathways we did not analyze, or, more likely, given its lack of cytotoxicity under some circumstances <xref ref-type="bibr" rid="pone.0007512-Metkar1">&#x0005b;55&#x0005d;</xref>, that its antiviral function is mediated by pathways other than apoptosis induction.</p><p>It is known that immune-mediated apoptosis induction, as the major threat to ECTV replication success, is mediated via several proapoptotic pathways <xref ref-type="bibr" rid="pone.0007512-Pardo3">&#x0005b;43&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007512-Pardo4">&#x0005b;44&#x0005d;</xref>. It is therefore likely that the full range of cell death pathways induced by gzmB has evolved due to selective pressure from pathogens like ECTV via its strategy to inhibit selective apoptosis pathways. In this respect, one could speculate that, in the course of its future co-evolution, ECTV may acquire more diverse apoptosis inhibiting capabilities. However, unimpaired virus replication may not necessarily constitute a successful viral strategy as an early demise of the host would curtail wide virus dissemination. On the other hand, it is possible that ECTV at least partially inhibits gzmB-mediated apoptosis induction. The comparison of peptide-pulsed target cells, which are labelled at 100&#x00025; but targeted only by a minority of anti-ECTV Tc cells on the one hand, and virus-infected target cells, which are only infected at about 80&#x00025; but display Tc cell determinants for the whole spectrum of anti-ECTV Tc cells on the other hand, would make it difficult to detect such a partial inhibition.</p><p>We also did not find any viral interference with calreticulin membrane translocation after Tc cell attack. This is important since it is now evident that dying cells signal the immune system to get activated against antigens contained in those cells and one of most critical is the calreticulin translocation. This indicates that ECTV does not affect its immunogenicity, i.e. proper phagocytosis of infected target cells and subsequent promotion of anti-viral/protective Tc responses <xref ref-type="bibr" rid="pone.0007512-Gardai1">&#x0005b;48&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007512-Obeid1">&#x0005b;49&#x0005d;</xref>.</p><p>Using MEF.BakxBax<sup>&#x02212;/&#x02212;</sup> cells and LCMV-immune <italic>ex vivo</italic> gzmB<sup>&#x0002b;</sup>Tc cells, we have previously shown that Bak and Bax were dispensable for PS translocation and caspase 3 activation induced by gzmB <xref ref-type="bibr" rid="pone.0007512-Pardo4">&#x0005b;44&#x0005d;</xref>. However, Bak and Bax were required for gzmB<sup>&#x0002b;</sup>Tc cell-induced cytochrome c release from mitochondria, a process that may contribute to caspase-3 activation via an amplification loop, including the apoptosome/caspase-9 complex <xref ref-type="bibr" rid="pone.0007512-Li1">&#x0005b;56&#x0005d;</xref>. We tested if ECTV infection of target cells interferes with the processes established in the LCMV system by using ECTV-immune <italic>ex vivo</italic> gzmB<sup>&#x0002b;</sup> Tc cells on ECTV &#x02013;infected MEF.BakxBax<sup>&#x02212;/&#x02212;</sup> or MEF.Casp3x7<sup>&#x02212;/&#x02212;</sup> targets. Although ECTV did not affect apoptosis induction by gzmB<sup>&#x0002b;</sup>Tc cells on MEF.wt, it partially inhibited apoptosis in MEF.BakxBax<sup>&#x02212;/&#x02212;</sup> cells. These data highlight the importance of the mitochondrial apoptotic pathway, triggered by gzmB, for efficient elimination of ECTV-infected cells. However ECTV replication was inhibited as much in MEF.BakxBax&#x02212;/&#x02212; cells as in wt cells, but not at all when casp3x7 were absent. This result indicates that casp3x7 are not only critically involved in apoptosis induced by mouse gzmB, but also in the control of ECTV replication <italic>in vitro</italic>. This finding emphasizes the importance of effectors caspases during apoptosis induced by gzmB and at the same time it suggests that mitochondrial amplification of gzmB-induced apoptosis is not needed to inhibit ECTV replication.</p><p>The complexity of cell death induction by antiviral Tc cells in virus-infected cells may thus reflect the evolutionary balance achieved between pathogen and host, in which the former needs to replicate sufficiently to ensure further spread, yet not enough to kill its host prematurely.</p><p>In conclusion, the pleiotropic nature of cell death induced by gzmB appears to be crucial to overcome the ability of ECTV to interfere with apoptosis induced by Tc cells. Since ECTV is a natural mouse pathogen and gzmB appears to be important for its <italic>in vivo</italic> control, an understanding of their interplays is of great importance in understanding host/parasite relationships.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Ethics statement</title><p>All experiments involving animals were performed in accordance with Australian National University (ANU) Animal Experimentations Ethics Committee.</p></sec><sec id="s4b"><title>Mouse strains and viruses</title><p>Inbred C57BL/6 (B6), and mouse strains deficient for gzmA (gzmA<sup>&#x02212;/&#x02212;</sup>), and gzmA&#x000d7;B (gzmA&#x000d7;B<sup>&#x02212;/&#x02212;</sup>), bred on the B6 background were maintained at the John Curtin School of Medical Research, Canberra and analysed for their genotypes as described <xref ref-type="bibr" rid="pone.0007512-Pardo1">&#x0005b;18&#x0005d;</xref>. Male mice of 8 to 10 weeks of age were used in all experiments and were performed in accordance with the local animal ethics authority.</p><p>The mouse orthopoxvirus ectromelia strains Moscow (Mo-ECTV) and Hampstead Egg (HE-ECTV) have been described <xref ref-type="bibr" rid="pone.0007512-Mullbacher2">&#x0005b;37&#x0005d;</xref>.</p></sec><sec id="s4c"><title>Generation of ex-vivo CD8<sup>&#x0002b;</sup> cells</title><p>Mice were infected with 10<sup>5</sup> pfu HE-ECTV i.v. according to established protocols <xref ref-type="bibr" rid="pone.0007512-Mllbacher1">&#x0005b;14&#x0005d;</xref>. On d6 post infection (p.i.), CD8<sup>&#x0002b;</sup> cells were positively selected from spleen using &#x003b1;-CD8-MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany) with an autoMACS (Miltenyi Biotec) and resuspended in MEM/5&#x00025; FCS prior to use in cytotoxic assays. Purity of selected CD8<sup>&#x0002b;</sup> cells was assessed by FACS staining and found to be between 95&#x02013;98&#x00025;.</p></sec><sec id="s4d"><title>Cell lines, cell culture and reagents</title><p>SV40 transformed mouse embryonic fibroblasts (MEFs) were cultured in MEM supplemented with 10&#x00025; FCS and 2-mercaptoethanol (10<sup>&#x02212;5</sup> M) at 37&#x000b0;C, 7&#x00025; CO<sub>2</sub>. BaxxBak<sup>&#x02212;/&#x02212;</sup> MEFs were generated as described previously <xref ref-type="bibr" rid="pone.0007512-Wei1">&#x0005b;57&#x0005d;</xref> and were generously provided by the S.J. Korsmeyer laboratory. Caspase 3x7<sup>&#x02212;/&#x02212;</sup> MEFs were generated as described previously and generously provided by Richard A. Flavell <xref ref-type="bibr" rid="pone.0007512-Lakhani1">&#x0005b;58&#x0005d;</xref>. The genotype of the various MEF cells was periodically tested by genomic PCR and western blot analysis. The mouse cell lines EL4.F15 and MC57G have been previously described <xref ref-type="bibr" rid="pone.0007512-Pardo2">&#x0005b;42&#x0005d;</xref>. In some cases the general caspase inhibitor Ac-ZVAD-fmk (Bachem; 100 &#x000b5;M) was added to cell cultures as described <xref ref-type="bibr" rid="pone.0007512-Pardo4">&#x0005b;44&#x0005d;</xref>.</p></sec><sec id="s4e"><title>Cell peptide pulsing and in vitro virus infection</title><p>Wt, Casp3x7<sup>&#x02212;/&#x02212;</sup>, BakxBax<sup>&#x02212;/&#x02212;</sup> MEFs, EL4 or MC57G cells were incubated with 10<sup>&#x02212;5</sup> M of the ectromelia immunodominant K<sup>b</sup> restricted peptide TSYKFESV-OH <xref ref-type="bibr" rid="pone.0007512-Tscharke1">&#x0005b;59&#x0005d;</xref> for 2 h at 37&#x000b0;C. Subsequently, cells were washed and used for the corresponding assays.</p><p>Wt, Casp3x7<sup>&#x02212;/&#x02212;</sup>, BakxBax<sup>&#x02212;/&#x02212;</sup> MEFs, EL4 or MC57G cells were infected with Mo or HE-ECTV at a multiplicity of infection of 3 pfu per cell (MOI 3&#x02236;1) for 4&#x02013;5 h at 35&#x000b0;C. Subsequently, cells were washed and used for the corresponding assays.</p></sec><sec id="s4f"><title>RT-PCR</title><p>Total RNA was extracted from up to 5&#x000d7;10<sup>6</sup> cells, using the QIAshredder spin columns, the RNeasy Mini Kit and the RNase-free DNase Kit (all from Qiagen, Hilden, Germany) according to manufacturer's instructions and converted to cDNA as described <xref ref-type="bibr" rid="pone.0007512-Martin1">&#x0005b;60&#x0005d;</xref>. Specific transcripts were amplified by using specific primers. The sense/antisense primers for <italic>gzmA</italic>, gzmB, gzmC, gzmK and <italic>GADPH</italic> and the PCR conditions have been previously described <xref ref-type="bibr" rid="pone.0007512-Pardo4">&#x0005b;44&#x0005d;</xref>.</p></sec><sec id="s4g"><title>EVM025 (F1L) sequencing</title><p>Total RNA was isolated from MEF.wt cells previously infected with Mo or HE-ECTV (MOI 3&#x02236;1, 4 h, 35&#x000b0;C) using the QIAshredder spin columns, the RNeasy Mini Kit and the RNase-free DNase Kit (all from Qiagen, Hilden, Germany) according to manufacturer's instructions and converted to cDNA as described <xref ref-type="bibr" rid="pone.0007512-Martin1">&#x0005b;60&#x0005d;</xref>. Full EVM025 cDNA was amplified by using the primers: <named-content content-type="gene">5&#x02032;-ACGGGATCCATGGACAATAGTATTTTGTCG-3</named-content> (forward) and <named-content content-type="gene">5&#x02032;-TCGGGATCCTCATATCATGTATTTGAGAGTC-3</named-content> (reverse). PCR was done as follows: 95&#x000b0;C/4 min. (1&#x000d7;); 95&#x000b0;C/30 sec., 51&#x000b0;C/1 min., 72&#x000b0;C/2 min. (5&#x000d7;); 95&#x000b0;C/30 sec., 58&#x000b0;C/1 min., 72&#x000b0;C/2 min. (35&#x000d7;); 72&#x000b0;C/7 min. PCR products were separated in agarose gel electrophoresis and fragments were purified and sequenced by using the BigDye Terminator v3.1 Cycle Sequencing Kit and a capillary-based Applied Biosystems 3730 DNA Analyzer at the John Curtin School of Medical Research's DNA sequencing facility.</p></sec><sec id="s4h"><title>Flow cytometry</title><p>Cell populations were analysed for cell surface marker expression and/or intracellular expression of gzmA and gzmB by FACS as described <xref ref-type="bibr" rid="pone.0007512-Pardo4">&#x0005b;44&#x0005d;</xref>. Rabbit immune serum (IS) specific for mouse gzmA (&#x003b1;mgzmA) and mouse gzmB (&#x003b1;-mgzmB) has been described <xref ref-type="bibr" rid="pone.0007512-Pardo5">&#x0005b;61&#x0005d;</xref>.</p></sec><sec id="s4i"><title>Lamp-1 mobilization assay</title><p>Lamp-1 (CD107a) expression in the cell membrane of <italic>ex vivo</italic> Tc cells was analysed as described <xref ref-type="bibr" rid="pone.0007512-Pardo4">&#x0005b;44&#x0005d;</xref>. Mock-treated, Peptide-pulsed or ECTV infected MEF cells were incubated with <italic>ex vivo</italic>-derived ECTV-immune Tc cells at 2&#x02236;1 effector&#x02236;target cell ratio (triplicates, 4&#x000d7;10<sup>4</sup> targets and 8&#x000d7;10<sup>4</sup> Tc cells/well). Subsequently, the mixed cell population was treated with 1 &#x000b5;l (final dilution 1&#x02236;200) of &#x003b1;-Lamp-1-FITC antibody (BD) in the presence of monensin for 6 h at 37&#x000b0;C, 7&#x00025; CO<sub>2</sub>. Non-attached cells were collected, labelled with &#x003b1;-CD8-APC antibody and analysed by FACS.</p></sec><sec id="s4j"><title>Analysis of pro-apoptotic processes</title><p>To analyse cell death induced by <italic>ex vivo</italic> Tc cells in target cells, mock-treated, peptide-pulsed or ECTV-infected cells were incubated with <italic>ex vivo</italic>-derived ECTV-immune Tc cells at 10&#x02236;1 effector&#x02236;target cell ratio for 3 h at 37&#x000b0;C, 7&#x00025;CO<sub>2</sub><xref ref-type="bibr" rid="pone.0007512-Pardo3">&#x0005b;43&#x0005d;</xref>. In some cases, Tc cells were previously labelled with CFSE 1 &#x000b5;M. Subsequently, different apoptotic parameters were tested in the target population (CD8<sup>&#x02212;</sup> or CFSE<sup>&#x02212;</sup>) by FACS with a FACScan (BD) and CellQuest&#x000ae; software as follows:</p></sec><sec id="s4k"><title>a&#x02003;Cell membrane and mitochondrial membrane perturbations</title><p>PS exposure and 7-amino-actinomycin D (7-AAD) uptake was analysed by FACS using annexin V-PE and 7-AAD from BD Pharmingen according to manufacturer's indications. The mitochondrial membrane potential was measured with the fluorescent probe 3,3&#x02032;-dihexyloxacarbocyanine iodide (DiOC<sub>6</sub>(3), Molecular Probes) <xref ref-type="bibr" rid="pone.0007512-Pardo4">&#x0005b;44&#x0005d;</xref>.</p></sec><sec id="s4l"><title>b&#x02003;Caspase-3 activation</title><p>Caspase 3 activation was analysed by FACS as described <xref ref-type="bibr" rid="pone.0007512-Pardo4">&#x0005b;44&#x0005d;</xref>. Cells were fixed with 4&#x00025; paraformaldehyde (PFA) and incubated with a FITC labelled monoclonal antibody against the active form of caspase-3 (clone C92605, BD Pharmingen) diluted in 0.1&#x00025; saponin in PBS. After two washes with 0.1&#x00025; saponin in PBS, cells were resuspended in 1&#x00025; PFA/PBS and analysed by FACS.</p></sec><sec id="s4m"><title>c&#x02003;Conformational change of Bax and Bak</title><p>Bak and Bax conformational change was analysed by FACS as described <xref ref-type="bibr" rid="pone.0007512-Pardo4">&#x0005b;44&#x0005d;</xref>. Briefly, cells were fixed in 4&#x00025; PFA, permeabilized with 0.1&#x00025; saponin in PBS/5&#x00025; FCS and incubated with polyclonal rabbit &#x003b1;-Bak (NT, Upstate Biotechnology), polyclonal rabbit &#x003b1;-Bax (NT, Upstate Biotechnology) or purified rabbit IgG (control). After washing (2&#x000d7;) with 0.1&#x00025; saponin in PBS, cells were incubated with &#x003b1;-rabbit-Alexa 647 antibody (Invitrogen) in 0.1&#x00025; saponin/PBS/5&#x00025; FCS, washed twice in 0.1&#x00025; saponin/PBS, resuspended in 1&#x00025; PFA/PBS and analysed by FACS.</p></sec><sec id="s4n"><title>d&#x02003;Analysis of calreticulin translocation</title><p>Calreticulin translocation to the outer plasma membrane was analysed as described <xref ref-type="bibr" rid="pone.0007512-Obeid1">&#x0005b;49&#x0005d;</xref>. Briefly, cells were incubated with rabbit anti-calreticulin pAb (Biomol) (30 min, 4&#x000b0;C), followed by goat anti-rabbit-alexa647 secondary antibody (30 min, 4&#x000b0;C). After washing twice PBS, cells were resuspended in a buffer containing 7-AAD and calreticulin was analysed in the 7-AAD<sup>&#x02212;</sup> cell population by FACS.</p></sec><sec id="s4o"><title>Analysis of viral titers during Tc cell induced cell death</title><p>Anti-ECTV CD8&#x0002b; Tc cells were generated and isolated as described above, except that mice were immunized with 10<sup>4</sup> instead of 10<sup>5</sup> pfu HE-ECTV, such that none of the infected mice contained any detectable ECTV in their spleens at the time of harvest. Effector and MEF target cells (infected for the indicated times before the assay) were co-incubated at 10&#x02236;1 effector&#x02236;target cell ratio at 37&#x000b0;C, 7&#x00025;CO<sub>2</sub>. After the indicated times of co-incubation, thoroughly mixed cell suspensions were analyzed for ECTV by plaque assay.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0007512.s001"><label>Figure S1</label><caption><p>Characterization of ECTV infection in MEF.wt cells. A, MEF.wt cells were mocked treated or infected with Mo- or HE-ECTV (moi 3&#x02236;1) for 5 or 18 hours. ECTV antigen was detected by using a polyclonal rabbit anti-ECTV serum and analysed by FACS as described in <xref ref-type="sec" rid="s4">materials and methods</xref>. Representative histograms (left panel) and means&#x0002b;/&#x02212;SEM of percent ECTV-antigen-positive cells from 6 (5 h) or 2 (18 h) independent experiments (right panel). B, MEF.wt cells were mocked treated or infected with Mo- or HE-ECTV (moi 3&#x02236;1) for 4 or 8 hours. Total RNA was isolated, EVM025 cDNA (F1L) was amplified, cloned and cDNA was analysed by agarose gel electrophoresis (left panel). The bands were purified and sequenced. Amino acid sequence alignments (right panel) are shown for the F1L BH3-like domain from Mo- and HE-ECTV and Vaccinia virus (Obtained from <xref ref-type="bibr" rid="pone.0007512-Postigo1">&#x0005b;34&#x0005d;</xref>). C, MEF.wt cells were mocked-treated or infected (5 h) with Mo- or HE-ECTV and subsequently treated with staurosporin 500 nM. After 12 h PS translocation (annexin V-PE staining) and membrane integrity (AAD staining) were analysed by FACS. Data are given as mean&#x0002b;/&#x02212;SEM of 3 independent experiments. D, MEF.wt cells were mocked-treated, EV-Kb-peptide-pulsed or infected with Mo- or HE-ECTV (moi 3&#x02236;1) for 5 h. Cell were washed and incubated for 3 hours more and PS translocation (annexin V-PE staining) and membrane integrity (AAD staining), mitochondrial membrane potential (DiOC6(3)) and calreticulin expression on the cell membrane were analysed by FACS as described in <xref ref-type="sec" rid="s4">materials and methods</xref>.</p><p>(1.57 MB TIF)</p></caption><media xlink:href="pone.0007512.s001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0007512.s002"><label>Figure S2</label><caption><p>Characterization of ex vivo Tc cells from ECTV infected mice. CD8&#x0002b; cells (anti-ECTV ex vivo Tc cells) were isolated by autoMACS from six-day HE-ECTV immune WT (B6), gzmA&#x02212;/&#x02212; or gzmA&#x000d7;B&#x02212;/&#x02212; mice. A, Total RNA was isolated and gzmA, gzmB, gzmC, and gzmK transcripts were analysed by RT-PCR. EL4 served as negative and day 6 primary allogeneic Tc cells as positive control. GADPH was analysed as housekeeping gene. B, intracellular gzmA and gzmB protein expression detected with anti-gzmA or anti-gzmB rabbit antiserum. Data shown are representative histograms of anti-gzm fluorescence (top panel) and means&#x0002b;/&#x02212;SEM of percent gzm&#x0002b; CD8&#x0002b; cells (bottom panel) from 3 independent experiments.</p><p>(2.07 MB TIF)</p></caption><media xlink:href="pone.0007512.s002.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ref-list><title>References</title><ref id="pone.0007512-Wyllie1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wyllie</surname><given-names>AH</given-names></name></person-group><year>1980</year><article-title>Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation.</article-title><source>Nature</source><volume>284</volume><fpage>555</fpage><lpage>556</lpage><pub-id pub-id-type="pmid">6245367</pub-id></mixed-citation></ref><ref id="pone.0007512-Russell1"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>JH</given-names></name><name><surname>Ley</surname><given-names>TJ</given-names></name></person-group><year>2002</year><article-title>Lymphocyte-mediated cytotoxicity.</article-title><source>Annu Rev Immunol</source><volume>20</volume><fpage>323</fpage><lpage>370</lpage><pub-id pub-id-type="pmid">11861606</pub-id></mixed-citation></ref><ref id="pone.0007512-Rouvier1"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rouvier</surname><given-names>E</given-names></name><name><surname>Luciani</surname><given-names>MF</given-names></name><name><surname>Golstein</surname><given-names>P</given-names></name></person-group><year>1993</year><article-title>Fas involvement in Ca(2&#x0002b;)-independent T cell-mediated cytotoxicity.</article-title><source>J Exp Med</source><volume>177</volume><fpage>195</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">7678113</pub-id></mixed-citation></ref><ref id="pone.0007512-Kagi1"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kagi</surname><given-names>D</given-names></name><name><surname>Vignaux</surname><given-names>F</given-names></name><name><surname>Ledermann</surname><given-names>B</given-names></name><name><surname>Burki</surname><given-names>K</given-names></name><name><surname>Depraetere</surname><given-names>V</given-names></name><etal/></person-group><year>1994</year><article-title>Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.</article-title><source>Science</source><volume>265</volume><fpage>528</fpage><lpage>530</lpage><pub-id pub-id-type="pmid">7518614</pub-id></mixed-citation></ref><ref id="pone.0007512-AshtonRickardt1"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashton-Rickardt</surname><given-names>PG</given-names></name></person-group><year>2005</year><article-title>The granule pathway of programmed cell death.</article-title><source>Crit Rev Immunol</source><volume>25</volume><fpage>161</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">16048434</pub-id></mixed-citation></ref><ref id="pone.0007512-Bossi1"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bossi</surname><given-names>G</given-names></name><name><surname>Griffiths</surname><given-names>GM</given-names></name></person-group><year>2005</year><article-title>CTL secretory lysosomes: biogenesis and secretion of a harmful organelle.</article-title><source>Semin Immunol</source><volume>17</volume><fpage>87</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">15582491</pub-id></mixed-citation></ref><ref id="pone.0007512-Voskoboinik1"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voskoboinik</surname><given-names>I</given-names></name><name><surname>Smyth</surname><given-names>MJ</given-names></name><name><surname>Trapani</surname><given-names>JA</given-names></name></person-group><year>2006</year><article-title>Perforin-mediated target-cell death and immune homeostasis.</article-title><source>Nat Rev Immunol</source><volume>6</volume><fpage>940</fpage><lpage>952</lpage><pub-id pub-id-type="pmid">17124515</pub-id></mixed-citation></ref><ref id="pone.0007512-Simon1"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>MM</given-names></name><name><surname>Kramer</surname><given-names>MD</given-names></name></person-group><year>1994</year><article-title>Granzyme A.</article-title><source>Methods Enzymol</source><volume>244</volume><fpage>68</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">7845244</pub-id></mixed-citation></ref><ref id="pone.0007512-Lieberman1"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lieberman</surname><given-names>J</given-names></name><name><surname>Fan</surname><given-names>Z</given-names></name></person-group><year>2003</year><article-title>Nuclear war: the granzyme A-bomb.</article-title><source>Curr Opin Immunol</source><volume>15</volume><fpage>553</fpage><lpage>559</lpage><pub-id pub-id-type="pmid">14499264</pub-id></mixed-citation></ref><ref id="pone.0007512-Trapani1"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trapani</surname><given-names>JA</given-names></name><name><surname>Sutton</surname><given-names>VR</given-names></name></person-group><year>2003</year><article-title>Granzyme B: pro-apoptotic, antiviral and antitumor functions.</article-title><source>Curr Opin Immunol</source><volume>15</volume><fpage>533</fpage><lpage>543</lpage><pub-id pub-id-type="pmid">14499262</pub-id></mixed-citation></ref><ref id="pone.0007512-Tschopp1"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tschopp</surname><given-names>J</given-names></name></person-group><year>1994</year><article-title>Granzyme B.</article-title><source>Methods Enzymology</source><volume>244</volume><fpage>80</fpage><lpage>87</lpage></mixed-citation></ref><ref id="pone.0007512-Kagi2"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kagi</surname><given-names>D</given-names></name><name><surname>Ledermann</surname><given-names>B</given-names></name><name><surname>Burki</surname><given-names>K</given-names></name><name><surname>Seiler</surname><given-names>P</given-names></name><name><surname>Odermatt</surname><given-names>B</given-names></name><etal/></person-group><year>1994</year><article-title>Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice.</article-title><source>Nature</source><volume>369</volume><fpage>31</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">8164737</pub-id></mixed-citation></ref><ref id="pone.0007512-Mullbacher1"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullbacher</surname><given-names>A</given-names></name><name><surname>Hla</surname><given-names>RT</given-names></name><name><surname>Museteanu</surname><given-names>C</given-names></name><name><surname>Simon</surname><given-names>MM</given-names></name></person-group><year>1999</year><article-title>Perforin is essential for control of ectromelia virus but not related poxviruses in mice.</article-title><source>J Virol</source><volume>73</volume><fpage>1665</fpage><lpage>1667</lpage><pub-id pub-id-type="pmid">9882377</pub-id></mixed-citation></ref><ref id="pone.0007512-Mllbacher1"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000fc;llbacher</surname><given-names>A</given-names></name><name><surname>Waring</surname><given-names>P</given-names></name><name><surname>Hia</surname><given-names>RT</given-names></name><name><surname>Tran</surname><given-names>T</given-names></name><name><surname>Chin</surname><given-names>S</given-names></name><etal/></person-group><year>1999</year><article-title>Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes.</article-title><source>Proc Natl Acad Sci U S A</source><volume>96</volume><fpage>13950</fpage><lpage>13955</lpage><pub-id pub-id-type="pmid">10570179</pub-id></mixed-citation></ref><ref id="pone.0007512-Pereira1"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>RA</given-names></name><name><surname>Simon</surname><given-names>MM</given-names></name><name><surname>Simmons</surname><given-names>A</given-names></name></person-group><year>2000</year><article-title>Granzyme A, a noncytolytic component of CD8(&#x0002b;) cell granules, restricts the spread of herpes simplex virus in the peripheral nervous systems of experimentally infected mice.</article-title><source>J Virol</source><volume>74</volume><fpage>1029</fpage><lpage>1032</lpage><pub-id pub-id-type="pmid">10623769</pub-id></mixed-citation></ref><ref id="pone.0007512-Riera1"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riera</surname><given-names>L</given-names></name><name><surname>Gariglio</surname><given-names>M</given-names></name><name><surname>Valente</surname><given-names>G</given-names></name><name><surname>Mullbacher</surname><given-names>A</given-names></name><name><surname>Museteanu</surname><given-names>C</given-names></name><etal/></person-group><year>2000</year><article-title>Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection.</article-title><source>Eur J Immunol</source><volume>30</volume><fpage>1350</fpage><lpage>1355</lpage><pub-id pub-id-type="pmid">10820381</pub-id></mixed-citation></ref><ref id="pone.0007512-Wang1"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Lobigs</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>E</given-names></name><name><surname>Mullbacher</surname><given-names>A</given-names></name></person-group><year>2004</year><article-title>Exocytosis and Fas mediated cytolytic mechanisms exert protection from West Nile virus induced encephalitis in mice.</article-title><source>Immunol Cell Biol</source><volume>82</volume><fpage>170</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">15061770</pub-id></mixed-citation></ref><ref id="pone.0007512-Pardo1"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardo</surname><given-names>J</given-names></name><name><surname>Balkow</surname><given-names>S</given-names></name><name><surname>Anel</surname><given-names>A</given-names></name><name><surname>Simon</surname><given-names>MM</given-names></name></person-group><year>2002</year><article-title>Granzymes are essential for natural killer cell-mediated and perf-facilitated tumor control.</article-title><source>Eur J Immunol</source><volume>32</volume><fpage>2881</fpage><lpage>2887</lpage><pub-id pub-id-type="pmid">12355441</pub-id></mixed-citation></ref><ref id="pone.0007512-Revell1"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Revell</surname><given-names>PA</given-names></name><name><surname>Grossman</surname><given-names>WJ</given-names></name><name><surname>Thomas</surname><given-names>DA</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Behl</surname><given-names>R</given-names></name><etal/></person-group><year>2005</year><article-title>Granzyme B and the downstream granzymes C and/or F are important for cytotoxic lymphocyte functions.</article-title><source>J Immunol</source><volume>174</volume><fpage>2124</fpage><lpage>2131</lpage><pub-id pub-id-type="pmid">15699143</pub-id></mixed-citation></ref><ref id="pone.0007512-Smyth1"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smyth</surname><given-names>MJ</given-names></name><name><surname>Thia</surname><given-names>KY</given-names></name><name><surname>Street</surname><given-names>SE</given-names></name><name><surname>MacGregor</surname><given-names>D</given-names></name><name><surname>Godfrey</surname><given-names>DI</given-names></name><etal/></person-group><year>2000</year><article-title>Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma.</article-title><source>J Exp Med</source><volume>192</volume><fpage>755</fpage><lpage>760</lpage><pub-id pub-id-type="pmid">10974040</pub-id></mixed-citation></ref><ref id="pone.0007512-vandenBroek1"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Broek</surname><given-names>ME</given-names></name><name><surname>Kagi</surname><given-names>D</given-names></name><name><surname>Ossendorp</surname><given-names>F</given-names></name><name><surname>Toes</surname><given-names>R</given-names></name><name><surname>Vamvakas</surname><given-names>S</given-names></name><etal/></person-group><year>1996</year><article-title>Decreased tumor surveillance in perforin-deficient mice.</article-title><source>J Exp Med</source><volume>184</volume><fpage>1781</fpage><lpage>1790</lpage><pub-id pub-id-type="pmid">8920866</pub-id></mixed-citation></ref><ref id="pone.0007512-vandenBroek2"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Broek</surname><given-names>MF</given-names></name><name><surname>Kagi</surname><given-names>D</given-names></name><name><surname>Zinkernagel</surname><given-names>RM</given-names></name><name><surname>Hengartner</surname><given-names>H</given-names></name></person-group><year>1995</year><article-title>Perforin dependence of natural killer cell-mediated tumor control in vivo.</article-title><source>Eur J Immunol</source><volume>25</volume><fpage>3514</fpage><lpage>3516</lpage><pub-id pub-id-type="pmid">8566046</pub-id></mixed-citation></ref><ref id="pone.0007512-Turk1"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turk</surname><given-names>B</given-names></name><name><surname>Stoka</surname><given-names>V</given-names></name></person-group><year>2007</year><article-title>Protease signalling in cell death: caspases versus cysteine cathepsins.</article-title><source>FEBS Lett</source><volume>581</volume><fpage>2761</fpage><lpage>2767</lpage><pub-id pub-id-type="pmid">17544407</pub-id></mixed-citation></ref><ref id="pone.0007512-Chipuk1"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chipuk</surname><given-names>JE</given-names></name><name><surname>Green</surname><given-names>DR</given-names></name></person-group><year>2006</year><article-title>Dissecting p53-dependent apoptosis.</article-title><source>Cell Death Differ</source><volume>13</volume><fpage>994</fpage><lpage>1002</lpage><pub-id pub-id-type="pmid">16543937</pub-id></mixed-citation></ref><ref id="pone.0007512-Adams1"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>JM</given-names></name><name><surname>Cory</surname><given-names>S</given-names></name></person-group><year>2007</year><article-title>The Bcl-2 apoptotic switch in cancer development and therapy.</article-title><source>Oncogene</source><volume>26</volume><fpage>1324</fpage><lpage>1337</lpage><pub-id pub-id-type="pmid">17322918</pub-id></mixed-citation></ref><ref id="pone.0007512-Benedict1"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benedict</surname><given-names>CA</given-names></name><name><surname>Norris</surname><given-names>PS</given-names></name><name><surname>Ware</surname><given-names>CF</given-names></name></person-group><year>2002</year><article-title>To kill or be killed: viral evasion of apoptosis.</article-title><source>Nat Immunol</source><volume>3</volume><fpage>1013</fpage><lpage>1018</lpage><pub-id pub-id-type="pmid">12407409</pub-id></mixed-citation></ref><ref id="pone.0007512-Boya1"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boya</surname><given-names>P</given-names></name><name><surname>Roumier</surname><given-names>T</given-names></name><name><surname>Andreau</surname><given-names>K</given-names></name><name><surname>Gonzalez-Polo</surname><given-names>RA</given-names></name><name><surname>Zamzami</surname><given-names>N</given-names></name><etal/></person-group><year>2003</year><article-title>Mitochondrion-targeted apoptosis regulators of viral origin.</article-title><source>Biochem Biophys Res Commun</source><volume>304</volume><fpage>575</fpage><lpage>581</lpage><pub-id pub-id-type="pmid">12729592</pub-id></mixed-citation></ref><ref id="pone.0007512-Callus1"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callus</surname><given-names>BA</given-names></name><name><surname>Vaux</surname><given-names>DL</given-names></name></person-group><year>2007</year><article-title>Caspase inhibitors: viral, cellular and chemical.</article-title><source>Cell Death Differ</source><volume>14</volume><fpage>73</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">16946729</pub-id></mixed-citation></ref><ref id="pone.0007512-Dobbelstein1"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobbelstein</surname><given-names>M</given-names></name><name><surname>Shenk</surname><given-names>T</given-names></name></person-group><year>1996</year><article-title>Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product.</article-title><source>J Virol</source><volume>70</volume><fpage>6479</fpage><lpage>6485</lpage><pub-id pub-id-type="pmid">8709286</pub-id></mixed-citation></ref><ref id="pone.0007512-Macen1"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macen</surname><given-names>JL</given-names></name><name><surname>Garner</surname><given-names>RS</given-names></name><name><surname>Musy</surname><given-names>PY</given-names></name><name><surname>Brooks</surname><given-names>MA</given-names></name><name><surname>Turner</surname><given-names>PC</given-names></name><etal/></person-group><year>1996</year><article-title>Differential inhibition of the Fas- and granule-mediated cytolysis pathways by the orthopoxvirus cytokine response modifier A/SPI-2 and SPI-1 protein.</article-title><source>Proc Natl Acad Sci U S A</source><volume>93</volume><fpage>9108</fpage><lpage>9113</lpage><pub-id pub-id-type="pmid">8799162</pub-id></mixed-citation></ref><ref id="pone.0007512-Pickup1"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pickup</surname><given-names>DJ</given-names></name><name><surname>Ink</surname><given-names>BS</given-names></name><name><surname>Hu</surname><given-names>W</given-names></name><name><surname>Ray</surname><given-names>CA</given-names></name><name><surname>Joklik</surname><given-names>WK</given-names></name></person-group><year>1986</year><article-title>Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases.</article-title><source>Proc Natl Acad Sci U S A</source><volume>83</volume><fpage>7698</fpage><lpage>7702</lpage><pub-id pub-id-type="pmid">3532120</pub-id></mixed-citation></ref><ref id="pone.0007512-Fischer1"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>SF</given-names></name><name><surname>Ludwig</surname><given-names>H</given-names></name><name><surname>Holzapfel</surname><given-names>J</given-names></name><name><surname>Kvansakul</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><etal/></person-group><year>2006</year><article-title>Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis.</article-title><source>Cell Death Differ</source><volume>13</volume><fpage>109</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">16003387</pub-id></mixed-citation></ref><ref id="pone.0007512-Wasilenko1"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wasilenko</surname><given-names>ST</given-names></name><name><surname>Banadyga</surname><given-names>L</given-names></name><name><surname>Bond</surname><given-names>D</given-names></name><name><surname>Barry</surname><given-names>M</given-names></name></person-group><year>2005</year><article-title>The vaccinia virus F1L protein interacts with the proapoptotic protein Bak and inhibits Bak activation.</article-title><source>J Virol</source><volume>79</volume><fpage>14031</fpage><lpage>14043</lpage><pub-id pub-id-type="pmid">16254338</pub-id></mixed-citation></ref><ref id="pone.0007512-Postigo1"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Postigo</surname><given-names>A</given-names></name><name><surname>Cross</surname><given-names>JR</given-names></name><name><surname>Downward</surname><given-names>J</given-names></name><name><surname>Way</surname><given-names>M</given-names></name></person-group><year>2006</year><article-title>Interaction of F1L with the BH3 domain of Bak is responsible for inhibiting vaccinia-induced apoptosis.</article-title><source>Cell Death Differ</source></mixed-citation></ref><ref id="pone.0007512-Aoyagi1"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoyagi</surname><given-names>M</given-names></name><name><surname>Zhai</surname><given-names>D</given-names></name><name><surname>Jin</surname><given-names>C</given-names></name><name><surname>Aleshin</surname><given-names>AE</given-names></name><name><surname>Stec</surname><given-names>B</given-names></name><etal/></person-group><year>2007</year><article-title>Vaccinia virus N1L protein resembles a B cell lymphoma-2 (Bcl-2) family protein.</article-title><source>Protein Sci</source><volume>16</volume><fpage>118</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">17123957</pub-id></mixed-citation></ref><ref id="pone.0007512-Fenner1"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenner</surname><given-names>F</given-names></name></person-group><year>1949</year><article-title>Mouse-pox; infectious ectromelia of mice; a review.</article-title><source>J Immunol</source><volume>63</volume><fpage>341</fpage><lpage>373</lpage><pub-id pub-id-type="pmid">15398116</pub-id></mixed-citation></ref><ref id="pone.0007512-Mullbacher2"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullbacher</surname><given-names>A</given-names></name><name><surname>Wallich</surname><given-names>R</given-names></name><name><surname>Moyer</surname><given-names>RW</given-names></name><name><surname>Simon</surname><given-names>MM</given-names></name></person-group><year>1999</year><article-title>Poxvirus-encoded serpins do not prevent cytolytic T cell-mediated recovery from primary infections.</article-title><source>J Immunol</source><volume>162</volume><fpage>7315</fpage><lpage>7321</lpage><pub-id pub-id-type="pmid">10358181</pub-id></mixed-citation></ref><ref id="pone.0007512-Wallich1"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallich</surname><given-names>R</given-names></name><name><surname>Simon</surname><given-names>MM</given-names></name><name><surname>Mullbacher</surname><given-names>A</given-names></name></person-group><year>2001</year><article-title>Virulence of mousepox virus is independent of serpin-mediated control of cellular cytotoxicity.</article-title><source>Viral Immunol</source><volume>14</volume><fpage>71</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">11270598</pub-id></mixed-citation></ref><ref id="pone.0007512-Turner1"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>SJ</given-names></name><name><surname>Silke</surname><given-names>J</given-names></name><name><surname>Kenshole</surname><given-names>B</given-names></name><name><surname>Ruby</surname><given-names>J</given-names></name></person-group><year>2000</year><article-title>Characterization of the ectromelia virus serpin, SPI-2.</article-title><source>J Gen Virol</source><volume>81</volume><fpage>2425</fpage><lpage>2430</lpage><pub-id pub-id-type="pmid">10993930</pub-id></mixed-citation></ref><ref id="pone.0007512-Brick1"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brick</surname><given-names>DJ</given-names></name><name><surname>Burke</surname><given-names>RD</given-names></name><name><surname>Minkley</surname><given-names>AA</given-names></name><name><surname>Upton</surname><given-names>C</given-names></name></person-group><year>2000</year><article-title>Ectromelia virus virulence factor p28 acts upstream of caspase-3 in response to UV light-induced apoptosis.</article-title><source>J Gen Virol</source><volume>81</volume><fpage>1087</fpage><lpage>1097</lpage><pub-id pub-id-type="pmid">10725436</pub-id></mixed-citation></ref><ref id="pone.0007512-Chen1"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>N</given-names></name><name><surname>Danila</surname><given-names>MI</given-names></name><name><surname>Feng</surname><given-names>Z</given-names></name><name><surname>Buller</surname><given-names>RM</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><etal/></person-group><year>2003</year><article-title>The genomic sequence of ectromelia virus, the causative agent of mousepox.</article-title><source>Virology</source><volume>317</volume><fpage>165</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">14675635</pub-id></mixed-citation></ref><ref id="pone.0007512-Pardo2"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardo</surname><given-names>J</given-names></name><name><surname>Balkow</surname><given-names>S</given-names></name><name><surname>Anel</surname><given-names>A</given-names></name><name><surname>Simon</surname><given-names>MM</given-names></name></person-group><year>2002</year><article-title>The differential contribution of granzyme A and granzyme B in cytotoxic T lymphocyte-mediated apoptosis is determined by the quality of target cells.</article-title><source>Eur J Immunol</source><volume>32</volume><fpage>1980</fpage><lpage>1985</lpage><pub-id pub-id-type="pmid">12115618</pub-id></mixed-citation></ref><ref id="pone.0007512-Pardo3"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardo</surname><given-names>J</given-names></name><name><surname>Bosque</surname><given-names>A</given-names></name><name><surname>Brehm</surname><given-names>R</given-names></name><name><surname>Wallich</surname><given-names>R</given-names></name><name><surname>Naval</surname><given-names>J</given-names></name><etal/></person-group><year>2004</year><article-title>Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis.</article-title><source>J Cell Biol</source><volume>167</volume><fpage>457</fpage><lpage>468</lpage><pub-id pub-id-type="pmid">15534000</pub-id></mixed-citation></ref><ref id="pone.0007512-Pardo4"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardo</surname><given-names>J</given-names></name><name><surname>Wallich</surname><given-names>R</given-names></name><name><surname>Martin</surname><given-names>P</given-names></name><name><surname>Urban</surname><given-names>C</given-names></name><name><surname>Rongvaux</surname><given-names>A</given-names></name><etal/></person-group><year>2008</year><article-title>Granzyme B-induced cell death exerted by ex vivo CTL: discriminating requirements for cell death and some of its signs.</article-title><source>Cell Death Differ</source><volume>15</volume><fpage>567</fpage><lpage>579</lpage><pub-id pub-id-type="pmid">18064039</pub-id></mixed-citation></ref><ref id="pone.0007512-Simon2"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>MM</given-names></name><name><surname>Hausmann</surname><given-names>M</given-names></name><name><surname>Tran</surname><given-names>T</given-names></name><name><surname>Ebnet</surname><given-names>K</given-names></name><name><surname>Tschopp</surname><given-names>J</given-names></name><etal/></person-group><year>1997</year><article-title>In vitro- and ex vivo-derived cytolytic leukocytes from granzyme A&#x000d7;B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells.</article-title><source>J Exp Med</source><volume>186</volume><fpage>1781</fpage><lpage>1786</lpage><pub-id pub-id-type="pmid">9362539</pub-id></mixed-citation></ref><ref id="pone.0007512-Pham1"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pham</surname><given-names>CT</given-names></name><name><surname>MacIvor</surname><given-names>DM</given-names></name><name><surname>Hug</surname><given-names>BA</given-names></name><name><surname>Heusel</surname><given-names>JW</given-names></name><name><surname>Ley</surname><given-names>TJ</given-names></name></person-group><year>1996</year><article-title>Long-range disruption of gene expression by a selectable marker cassette.</article-title><source>Proc Natl Acad Sci U S A</source><volume>93</volume><fpage>13090</fpage><lpage>13095</lpage><pub-id pub-id-type="pmid">8917549</pub-id></mixed-citation></ref><ref id="pone.0007512-Krzyzowska1"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krzyzowska</surname><given-names>M</given-names></name><name><surname>Schollenberger</surname><given-names>A</given-names></name><name><surname>Skierski</surname><given-names>J</given-names></name><name><surname>Niemialtowski</surname><given-names>M</given-names></name></person-group><year>2002</year><article-title>Apoptosis during ectromelia orthopoxvirus infection is DEVDase dependent: in vitro and in vivo studies.</article-title><source>Microbes Infect</source><volume>4</volume><fpage>599</fpage><lpage>611</lpage><pub-id pub-id-type="pmid">12048029</pub-id></mixed-citation></ref><ref id="pone.0007512-Gardai1"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardai</surname><given-names>SJ</given-names></name><name><surname>McPhillips</surname><given-names>KA</given-names></name><name><surname>Frasch</surname><given-names>SC</given-names></name><name><surname>Janssen</surname><given-names>WJ</given-names></name><name><surname>Starefeldt</surname><given-names>A</given-names></name><etal/></person-group><year>2005</year><article-title>Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte.</article-title><source>Cell</source><volume>123</volume><fpage>321</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">16239148</pub-id></mixed-citation></ref><ref id="pone.0007512-Obeid1"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obeid</surname><given-names>M</given-names></name><name><surname>Tesniere</surname><given-names>A</given-names></name><name><surname>Ghiringhelli</surname><given-names>F</given-names></name><name><surname>Fimia</surname><given-names>GM</given-names></name><name><surname>Apetoh</surname><given-names>L</given-names></name><etal/></person-group><year>2007</year><article-title>Calreticulin exposure dictates the immunogenicity of cancer cell death.</article-title><source>Nat Med</source><volume>13</volume><fpage>54</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">17187072</pub-id></mixed-citation></ref><ref id="pone.0007512-Tewari1"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tewari</surname><given-names>M</given-names></name><name><surname>Telford</surname><given-names>WG</given-names></name><name><surname>Miller</surname><given-names>RA</given-names></name><name><surname>Dixit</surname><given-names>VM</given-names></name></person-group><year>1995</year><article-title>CrmA, a poxvirus-encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis.</article-title><source>J Biol Chem</source><volume>270</volume><fpage>22705</fpage><lpage>22708</lpage><pub-id pub-id-type="pmid">7559394</pub-id></mixed-citation></ref><ref id="pone.0007512-Blanden1"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanden</surname><given-names>RV</given-names></name></person-group><year>1974</year><article-title>T cell response to viral and bacterial infection.</article-title><source>Transplant Rev</source><volume>19</volume><fpage>56</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">4152201</pub-id></mixed-citation></ref><ref id="pone.0007512-Mullbacher3"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullbacher</surname><given-names>A</given-names></name><name><surname>Blanden</surname><given-names>RV</given-names></name></person-group><year>2004</year><article-title>T-cell-mediated control of poxvirus infection in mice.</article-title><source>Prog Mol Subcell Biol</source><volume>36</volume><fpage>39</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">15171606</pub-id></mixed-citation></ref><ref id="pone.0007512-Mullbacher4"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullbacher</surname><given-names>A</given-names></name><name><surname>Ebnet</surname><given-names>K</given-names></name><name><surname>Blanden</surname><given-names>RV</given-names></name><name><surname>Hla</surname><given-names>RT</given-names></name><name><surname>Stehle</surname><given-names>T</given-names></name><etal/></person-group><year>1996</year><article-title>Granzyme A is critical for recovery of mice from infection with the natural cytopathic viral pathogen, ectromelia.</article-title><source>Proc Natl Acad Sci U S A</source><volume>93</volume><fpage>5783</fpage><lpage>5787</lpage><pub-id pub-id-type="pmid">8650169</pub-id></mixed-citation></ref><ref id="pone.0007512-Regner1"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regner</surname><given-names>M</given-names></name><name><surname>Pavlinovic</surname><given-names>L</given-names></name><name><surname>Koskinen</surname><given-names>A</given-names></name><name><surname>Young</surname><given-names>N</given-names></name><name><surname>Trapani</surname><given-names>JA</given-names></name><etal/></person-group><year>2009</year><article-title>Cutting edge: Rapid and efficient in vivo cytotoxicity by cytotoxic T cells is independent of granzymes A and B.</article-title><source>J Immunol</source><volume>183</volume><fpage>37</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">19525394</pub-id></mixed-citation></ref><ref id="pone.0007512-Metkar1"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metkar</surname><given-names>SS</given-names></name><name><surname>Menaa</surname><given-names>C</given-names></name><name><surname>Pardo</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Wallich</surname><given-names>R</given-names></name><etal/></person-group><year>2008</year><article-title>Human and mouse granzyme A induce a proinflammatory cytokine response.</article-title><source>Immunity</source><volume>29</volume><fpage>720</fpage><lpage>733</lpage><pub-id pub-id-type="pmid">18951048</pub-id></mixed-citation></ref><ref id="pone.0007512-Li1"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Nijhawan</surname><given-names>D</given-names></name><name><surname>Budihardjo</surname><given-names>I</given-names></name><name><surname>Srinivasula</surname><given-names>SM</given-names></name><name><surname>Ahmad</surname><given-names>M</given-names></name><etal/></person-group><year>1997</year><article-title>Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.</article-title><source>Cell</source><volume>91</volume><fpage>479</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">9390557</pub-id></mixed-citation></ref><ref id="pone.0007512-Wei1"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>MC</given-names></name><name><surname>Zong</surname><given-names>WX</given-names></name><name><surname>Cheng</surname><given-names>EH</given-names></name><name><surname>Lindsten</surname><given-names>T</given-names></name><name><surname>Panoutsakopoulou</surname><given-names>V</given-names></name><etal/></person-group><year>2001</year><article-title>Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death.</article-title><source>Science</source><volume>292</volume><fpage>727</fpage><lpage>730</lpage><pub-id pub-id-type="pmid">11326099</pub-id></mixed-citation></ref><ref id="pone.0007512-Lakhani1"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakhani</surname><given-names>SA</given-names></name><name><surname>Masud</surname><given-names>A</given-names></name><name><surname>Kuida</surname><given-names>K</given-names></name><name><surname>Porter</surname><given-names>GA</given-names><suffix>Jr</suffix></name><name><surname>Booth</surname><given-names>CJ</given-names></name><etal/></person-group><year>2006</year><article-title>Caspases 3 and 7: key mediators of mitochondrial events of apoptosis.</article-title><source>Science</source><volume>311</volume><fpage>847</fpage><lpage>851</lpage><pub-id pub-id-type="pmid">16469926</pub-id></mixed-citation></ref><ref id="pone.0007512-Tscharke1"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tscharke</surname><given-names>DC</given-names></name><name><surname>Karupiah</surname><given-names>G</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Palmore</surname><given-names>T</given-names></name><name><surname>Irvine</surname><given-names>KR</given-names></name><etal/></person-group><year>2005</year><article-title>Identification of poxvirus CD8&#x0002b; T cell determinants to enable rational design and characterization of smallpox vaccines.</article-title><source>J Exp Med</source><volume>201</volume><fpage>95</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">15623576</pub-id></mixed-citation></ref><ref id="pone.0007512-Martin1"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>P</given-names></name><name><surname>Wallich</surname><given-names>R</given-names></name><name><surname>Pardo</surname><given-names>J</given-names></name><name><surname>Mullbacher</surname><given-names>A</given-names></name><name><surname>Munder</surname><given-names>M</given-names></name><etal/></person-group><year>2005</year><article-title>Quiescent and activated mouse granulocytes do not express granzyme A and B or perforin: similarities or differences with human polymorphonuclear leukocytes?</article-title><source>Blood</source><volume>106</volume><fpage>2871</fpage><lpage>2878</lpage><pub-id pub-id-type="pmid">15998831</pub-id></mixed-citation></ref><ref id="pone.0007512-Pardo5"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardo</surname><given-names>J</given-names></name><name><surname>Wallich</surname><given-names>R</given-names></name><name><surname>Ebnet</surname><given-names>K</given-names></name><name><surname>Iden</surname><given-names>S</given-names></name><name><surname>Zentgraf</surname><given-names>H</given-names></name><etal/></person-group><year>2007</year><article-title>Granzyme B is expressed in mouse mast cells in vivo and in vitro and causes delayed cell death independent of perforin.</article-title><source>Cell Death Differ</source><volume>14</volume><fpage>1768</fpage><lpage>1779</lpage><pub-id pub-id-type="pmid">17599099</pub-id></mixed-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This work was supported in part by grants SAF2008-02139 from Ministerio de Ciencia e Innovaci&#x000f3;n (MICINN) (Spain) and PI076/08 from Gobierno de Arag&#x000f3;n and by Australian National Health and Medical Research Council. JP was supported by an EMBO short-term fellowship and Fundaci&#x000f3;n Agencia Aragonesa para Investigaci&#x000f3;n y Desarrollo (ARAID, Spain). EMG was supported by Consejo Superior de Investigaciones Cient&#x000ed;ficas (CSIC). MR was supported by an Australian Academy of Sciences Travel Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article>